683746-68-1

683746-68-1 structure

Name: JNJ 5207787
Chemical Name: (E)-N-(1-acetyl-2,3-dihydroindol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]prop-2-enamide
CAS Number: 683746-68-1
Molecular Formula: C₃₂H₃₈N₄O₂
Molecular Weight: 510.67000
Catalog: Signaling Pathways GPCR/G Protein Neuropeptide Y Receptor
Create Date: 2017-07-31 14:37:28
Modify Date: 2024-01-10 12:23:36
JNJ-5207787 is a nonpeptidic, selective and penetrate the blood-brain barrier neuropeptide Y Y2 receptor (Y2) antagonist. JNJ-5207787 inhibits the binding of peptide YY (PYY) with pIC50s of 7.0 and 7.1 for human Y2 receptor and rat Y2 receptor, respectively. JNJ-5207787 is >100-fold selective versus human Y1, Y4, and Y5 receptors[1].

Name	(E)-N-(1-acetyl-2,3-dihydroindol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]prop-2-enamide
Synonyms	unii-ow44b6fa0y

Description	JNJ-5207787 is a nonpeptidic, selective and penetrate the blood-brain barrier neuropeptide Y Y2 receptor (Y2) antagonist. JNJ-5207787 inhibits the binding of peptide YY (PYY) with pIC50s of 7.0 and 7.1 for human Y2 receptor and rat Y2 receptor, respectively. JNJ-5207787 is >100-fold selective versus human Y1, Y4, and Y5 receptors[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> Neuropeptide Y Receptor
Target	human Y2 receptor:7.0 (pIC50) rat Y2 receptor:7.1 (pIC50)
In Vitro	JNJ-5207787 (0.01, 0.1, 1, 10 μM) has antagonistic properties and inhibits the PYY-stimulated [35S]GTPγS binding to basal level with a p IC50 corr of 7.20[1]. JNJ-5207787 (10 μM; 15 min) inhibits [125I]PYY labeling in lateral septum, cerebellum, ventral tegmental area, substantia nigra, hippocampus, septum, amygdala, and hypothalamus[1].
In Vivo	JNJ-5207787 (i.p.; 30 mg/kg) penetrates into the brain (Cmax=1351 ng/ml at 30 min) and occupies Y2 receptor binding sites[1]. Animal Model: Sixteen female Sprague-Dawley Rats (approximately 300 g of body weight)[1] Dosage: 30 mg/kg Administration: IP Result: Penetrated into the brain (Cmax=1351 ng/ml at 30 min) and occupied Y2 receptor binding sites.
References	[1]. Bonaventure P, et al. Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide YY2 receptor. J Pharmacol Exp Ther. 2004 Mar;308(3):1130-7.

Molecular Formula	C₃₂H₃₈N₄O₂
Molecular Weight	510.67000
Exact Mass	510.29900
PSA	67.65000
LogP	5.56128

683746-68-1	1259026-14-6
708275-58-5	951135-07-2
1917306-14-9	443797-96-4
1428327-35-8	871313-59-6
2086772-26-9	943540-75-8
1894535-73-9	1903477-61-1
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
62102-18-5	6906-52-1
2034247-45-3	930439-75-1